• Libraries
    • Log in to:
    View Item 
    •   MSpace Home
    • Faculty of Graduate Studies (Electronic Theses and Practica)
    • FGS - Electronic Theses and Practica
    • View Item
    •   MSpace Home
    • Faculty of Graduate Studies (Electronic Theses and Practica)
    • FGS - Electronic Theses and Practica
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    The role of Trappin-2 and RANTES in mediating resistance to HIV-1 infection

    Thumbnail
    View/Open
    Diana_Mlinar_Masters_Thesis[1].pdf (8.232Mb)
    Date
    2009-01-06
    Author
    Mlinar, Diana
    Metadata
    Show full item record
    Abstract
    There are currently more than 33 million people worldwide who are infected with HIV-1 despite development of novel treatments and knowledge of prevention strategies. Within the Pumwani area of Nairobi, Kenya there is a group of commercial sex workers who are highly exposed to HIV-1. A small subset of these women have been classified as resistant to HIV-1 infection as they remain HIV un-infected despite as many as 60 unprotected sexual exposures to HIV each year. A better understanding of such a natural model of HIV resistance would be invaluable to inform the development of a protective HIV vaccine or microbicide. Globally, heterosexual transmission of HIV across mucosal surfaces is responsible for the bulk of new infections and thus it is important to examine both the macro and the micro environments of the vaginal mucosa in efforts to determine what enhances and what thwarts HIV-infection. Previous studies have shown elevated levels of RANTES, a natural ligand for the dominant HIV co-receptor CCR5, in cervicovaginal secretions of HIV-resistant women. Additionally, a novel HIV-inhibitor, Trappin-2 was previously shown to be elevated in cervicovaginal secretions of HIV-resistant women. To test the hypothesis that RANTES and Trappin-2 in cervicovaginal fluid are important mediators of HIV resistance we will: 1) measure RANTES in a much larger group of women from the Pumwani cohort, and 2) measure Trappin-2 levels in samples taken at different time points, and 3) correlate Trappin-2 levels in cervicovaginal fluid with biological confounding variables, and 4) investigate whether SDF-1 plays a role in HIV-disease progression in HIV-positive women.
    URI
    http://hdl.handle.net/1993/3104
    Collections
    • FGS - Electronic Theses and Practica [25515]

    DSpace software copyright © 2002-2016  DuraSpace
    Contact Us | Send Feedback
    Theme by 
    Atmire NV
     

     

    Browse

    All of MSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    Login

    Statistics

    View Usage Statistics

    DSpace software copyright © 2002-2016  DuraSpace
    Contact Us | Send Feedback
    Theme by 
    Atmire NV